149 Pm, 166 Ho, 161 Tb and 177 Lu conjugated to chemical agents (monoclonal antibodies, polypeptide, etc.) have the appropriate decay characteristics for imaging and therapeutic studies and consequently the potential to be useful in radiotherapy and diagnosis. These carrier-free radioisotopes can be produced by neutron irradiation of a lanthanide target followed by β − decay, and a posterior radiochemical separation of the daughter radionuclide from macro-amounts of the parent target. In order to produce carrier free 149 Pm, 161 Tb, 166 Ho and 177 Lu for radiotherapy, with a radionuclide purity of more than 99.9%, a device production was developed based on separation of Nd/Pm, Gb/Tb, Dy/Ho and Yb/Lu by extraction chromatography.
Introduction
Targeted tumor radiotherapy uses radionuclides conjugated to chemically-guided agents such as labelled monoclonal antibodies or isotopically-labelled polypeptide. These agents require radioisotopes with high specific activity, high LET particle emissions, photon emissions for monitoring therapy with imaging and follow-up as well as adsorbed dose distribution and half-lives long enough to allow the preparation and distribution of radiopharmaceuticals [1] - [6] . High energy beta emitting radionuclides are preferentially used in these agents to kill tumoral cells [4] . Radioactive lanthanides such as 149 Pm, 161 Tb, 166 Ho and 177 Lu, have a great potential in radiotherapy because they are beta or Auger-electron emitters with just enough gammas to enable imaging, with halflives long enough to allow preparation and distribution of the radiopharmaceuticals, and can be prepared at high specific activities (carrier-free) (see Table 1 ).
Chemically, lanthanides (Ln 3+ ) have the ability to replace Ca 2+ in biological systems (e.g. enzymes, proteins, cells, cytoplasm). Additionally, they could cause the inhibition of collagenase or lymphocyte activation, the sta- bilization of collagen fibrils, the stimulus-mediated cell secretion, neutrophil chemotaxis and aggregation, etc.
[1]-[5] [7] . Lanthanides display strong oxyphilicity and form high thermodynamic stability complexes, especially those derived from poly (aminocarboxilic) acids, which enables them to remain intact while diffusing into extracellular spaces with rapid clearance through kidneys [8] . On the other hand, all lanthanides have similar chemical properties regarding labeling, therefore, radiolanthanides that have been used for therapy, such as 153 Sm and 177 Lu, might easily be replaced with other radiolanthanides in accordance with their application. For example, high energy beta emitters such as 149 Pm or 166 Ho are efficient for metastases while the low-energy electron emitters as 161 Tb and 177 Lu might be suitable for micrometastases therapy [4] [9] . A large number of clinical studies focused on the use of 177 Lu for therapeutic treatment have been reported [5] [10]- [13] : 177 Lu-DOTATOC, 177 Lu-DOTATATE, 177 Lu-DOTA-HSAM and 177 Lu-DOTA-Octreotate have been used as receptor-positive tumors [10] [11] [14] [15], 177 Lu-octreotate in advanced low-grade neuroendocrine tumors [15] [16], 177 Lu-RM2 for prostate cancer [17] , 177 Lu-antitenascin monoclonal antibody (mAb) 81C6 as a targeted radiotherapeutic in patients with brain tumors [18] , [ 177 Lu]Lu-AMBA and 177 Lu DOTA-chelated bombesin (BN) as targeted radiotherapy of tumors expressing gastrin releasing peptide receptors [19] [20] or 177 Lumonoclonal antibody (mAb) L8A4 for the treatment of residual tumor margins remaining after surgical debulking of brain tumors [21] [22] . 161 Tb is a low-energy β − emitter similar to 177 Lu that has been less used and studied than 177 Lu. However possesses a high potential for treating small tumor cell clusters or even targeting single cells, due to its ability to emit a significant amount of conversion and Auger electrons, which provides much higher local dose density due to their shorter range in tissue (0.5 -30 μm). For example, 161 Tb-DTPA-octreotide has been reported as a somatostatin analogue for intraoperative scanning [2] [11] .
The high beta energy emitter 166 Ho has being used with: 166 Ho-DOTMP, 166 Ho-EDTMP as bone agent in the treatment of multiple myeloma (for bone marrow ablation) [5] [12] [13] , 166 Ho macroaggregates such as 166 Ho-FHMA or 166 Ho-poly(L-lactic acid) in radiation synovectomy or hepatic tumors [2] [23] [24] , 166 Ho and immature DCs to treat irreversible melanoma or as an adjuvant therapy after surgery [25] 166 Dy/ 166 Ho generator system, for myeloablative radiotherapy and subsequent stem cell transplantation [26] or self-expandable covered metallic stent incorporated with 166 Ho for delivering intraluminal brachytherapy as well as for internal bile drainage in malignant biliary stricture [27] . 149 Pm, a moderate beta energy emitter, has been the least exploited of these radiolanthanides. Just two studies have been reported: 149 Pm-DO3A-amide-βAla-BBN concerning in vivo tracking of the therapeutic dose [28] and biodistribution studies conducted with 149 Pm and 177 Lu-DOTA-conjugated vitronectin receptor (α v β 3 ) antagonist-RGD [29] .
Carrier-free radiolanthanides of high specific activity can be produced in nuclear reactors via neutron irradiation of massive lanthanide targets (>1 mg), as described in the reaction 1, followed by a radiochemical separation of the daughter radionuclide ( ) [11] [30]- [37] .
Considering that the development of potential radiotherapy agents greatly depends on a consistent and reasonably priced supply of high specific activity radiolanthanides (carrier-free), the objective of this work was to develop a device production in order to obtain the carrier free radiolanthanides: 149 Pm, 161 Tb, 166 Ho and 177 Lu. The process, previously developed by our group, is based on radiochemical separation of these radiolanthanides from irradiated natural targets, using an extraction chromatographic resin and for this specific purpose a device was designed and built.
Separation Process of Radiolanthanides
The separation conditions of the Nd/Pm, Gd/Tb, Dy/Ho and Yb/Lu pairs, shown in Table 2 Tb, 166 Dy/ 166 Ho and 177 Yb/ 177 Lu) (See Table 3 ), 2) Dissolution of the radioactive salts containing the parent/ daughter pair in 0.15 mol/L HNO 3 and adsorption into the chromatographic column loaded with Ln SPS Eichrom resin, 3) Desorption of parent by elution with HNO 3 , 4) Desorption of daughter by elution with HNO 3 , 5) Precipitation of lanthanide hydroxides Ln(OH) 3 by addition of NaOH to daughter's eluate, and 6) Re-dissolution of lanthanide hydroxides Ln(OH) 3 with 0.1 mol/L HCl. , under the conditions marked in Table 3 . The parent lanthanide of the parent/daughter pairs: Nd/Pm, Gd/Tb, Dy/Ho and Yb/Lu is eluted at first during the chromatographic separation process. This solution can be re-crystallized as nitrate and the enriched target recover for a new irradiation. The 149 Pm, 161 Tb, 166 Ho and 177 Lu solutions obtained at high concentrations of nitric acid (3 to 8 M) are transformed to lanthanide chloride salts by adding NaOH, until reaching a pH value of 7 to form lanthanide hydroxides Ln(OH) 3 , which were re-dissolved in 4 mL of 0.1 N HCl to get lanthanide chlorides solutions ( 
Radiolanthanide Separation Device
The radiolanthanide separation device, called DISER, was designed and built from separation methodology described previously, for routinely production of carrier-free 149 Pm, 161 Tb, 166 Ho and 177 Lu with a radionuclide purity of more than 99.9%. The DISER was built at the National Institute of Nuclear Research (ININ) in Mexico by groups from the Radioactive Materials Research Laboratory (LIMR) and the Prototype Fabrication Department. The device subsequently described is the result of several arrangements and modifications.
The DISER was placed in a hot cell consisted of 1) Labware support stands, 2) Chromatographic columns support stand, 3) Reagent Access System and 4) Opening system of the irradiation container (see Figure 3) . A description of each component and system is presented below.
Labware support stand. The DISER has three acrylic support stands, two are held at the top of the cell to place beakers used in the separation process (A1). Both support stands are rotatory in order to facilitate the handling and arrangement of labware during the process. The third is placed on the left wall of the cell and is constituted by eight semi-hollow cylindrical bases where the chromatographic columns are stocked (A2) (see Figure 3) . Yb/ 177 Lu) is performed. The carousel is constructed all in acrylic and its stainless steel shaft is screwed onto the cell (see Figure 3) . The support carousel consists of: 1) a rotating disk which can hold beakers to receive the eluates from the separation process (B1) and 2) two supports fixed on the carousel's shaft, one holds 2 chromatographic columns for the separation process and dissolution of lanthanide hydroxides (B2), and the other one in shape of funnel to add the NaOH to the daughter's eluates (B3). This neutralization reaction is air-cooled. The columns base is also gyratory and can be fitted to varing heights.
The glass chromatographic columns (80 × 12 mm) with a coarse fritted disc are used in the separation process-packaged with 2 g of Eichrom's Ln SPS resin (50 -100 μm)-and the dissolution of lanthanide hydroxides, filled with glass wool and Whatman No.1 filter paper.
Reagent Access System is located outside the hot cell, at the top and consists of a glass separatory funnel with cap and stopcork holded to an acrilic support (C). The funnel tip is connected to a glass pipette located directly on the chromatographic column. This system allows to introduce to the cell the HNO 3 solutions requiered for the separation and dissolution process, easily and safely without openning the hot cell.
Opening system of the irradiation container. The radioactive lanthanide nitrate salts contained in quartz ampoules are uncapped in the opening system. The latter is constituted by an acrylic support in the form of inverted "L" (D); the ampoule is held into the large base (D1) which can slide and in the cutter ampoule base (D2) the tip of the quartz ampoule is inserted into the hole opener and by applying a torque, the top is cracked.
Production of Radiolanthanides in the DISER

Before separation process
The DISER is perfectly cleaned; the chromatographic columns (Wheaton 80 × 12 mm) are packed with with Ln SPS Eichrom resin (B2) and with glass wool and Whatman No. 1 filter paper (B3). All solutions are prepared: HNO 3 solutions and 4 mol/L HCl. The chromatographic columns are placed into the Labware support stand (A2), the beakers properly numbered and the final product vial into the carousel (B1) and the NaOH pearls and the 0.15 mol/L HNO 3 solution into support stands (A1). The separation efficiency and the radionuclide purities are then determined to the final product with a coaxial gamma detector HPGe (Canberra 7229P) connected to a PC-multichannel analyzer (ACCUSSPECT-A, Canberra). Chemical purity should be determined by ICP.
Discussion
Radiochemical separations of the 149 Pm, 161 Tb, 166 Ho and 177 Lu from the macro-amounts of the neodinium, gadolinium, dysprosium and ytterbium targets, performed in the DISER by the methodology proposed, allow to separate: 1) Gadolinium and Terbium with an efficiency of 100%, recovering the 161 Tb with a radionuclide purity of 100%; 2) Neodymium and Promethium with an efficiency of 98.4% and a
149
Pm radionuclide purity of 99.9%; 3) Dysprosium and Holmium with an efficiency of 100%, obtaining 100% pure 166 Ho; and 4) Ytterbium and Lutetium with an efficiency of 89.7% , recovering the 177 Lu at a 99.9% radionuclide purity if the first 6 mL of the 177 Lu eluate are removed. The recovery efficiencies of the lanthanides chlorides after precipitation of the hydroxides and the dissolution with 0.1 mol/L HCl are: 98.5%, 96.5%, 96.9% and 99.6% for 149 Pm, 161 Tb, 166 Ho and 177 Lu respectively. The remotion of The sodium nitrate salts are removed in the aqueous phase and only the hydroxide precipitates are redissolved. In the separation protocol proposed, the pH values to precipitate the lanthanide nitrate solutions was fixed at 7, considering that the pH values reported by the literature, at which lanthanides precipitate are: Nd (6.7), Pm (6.6), Gd(6.4), Tb (6.3), Dy (6.1), Ho (6.1), Yb (5.6) and Lu (5.5), values lower than 7 [40] .
Conclusion
A radiolanthanide separation device (DISER) was designed and built to standardize the separation process of the four pairs:
149 Nd/ 177 Lu. The separation process of pairs reported here consists to six stages: 1) Target Irradiation; 2) Dissolution of the irradiated target to be loaded into the chromatographic column; 3) Desorption of parent; 4) Desorption of daughter; 5) Formation of lanthanide hydroxides; and 6) Re-dissolution of lanthanide hydroxides with HCl. The adequate execution of this process, for a period of 20 -25 min, is able to produce carrier-free 149 Pm, 161 Tb, 166 Ho or 177 Lu and with a radionuclide purity of more than 99.9%. It is important to remark that for an optimal performance is important to use the following separation conditions: for Neodymium and Promethium use 0.18 and 1.5 M HNO 3 , for Gadolinium and Terbium use 0.8 and 3 M HNO 3 , for Dysprosium and Holmium use 1.5 M HNO 3 and for Ytterbium and Lutetium use 3.4 and 8 M HNO 3 respectively.
